Valiant Organics FY26 Net Profit Surges to ₹34.36 Crore

Valiant Organics approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting a significant turnaround to a net profit of ₹34.36 crore from a loss.
The Board identified Pharma Business as a new reportable segment alongside existing Specialty Chemicals, in compliance with Ind AS 108.
The company re-appointed Ketki D. Visariya as Cost Auditor and Manish Modi & Associates as Internal Auditor for FY 2026–27.
Statutory auditors Gokhale & Sathe issued un-modified audit opinions on both standalone and consolidated financial statements for FY26.